| |
|
|
|
Aeglea Biothera  
|
|
7.59 -0.3 (-0.04%) |
01-20 12:33 |
|
Open: |
7.89 |
Pre close: |
7.89 |
Target:
|
10.44 
|
|
High: |
7.9799 |
Low: |
7.5569 |
Resistance:
|
8.94
9.78
|
|
Volume: |
116,354 |
Market Cap: |
364M |
Support:
|
7.58
6.31
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.92
 |
MACD |
MACD(12,26):
|
-0.15 |
|
MA(20): |
8.10 |
Signal(12,26,9): |
-0.12 |
|
MA(100): |
8.00 |
Stochastic Oscillator |
%K(14,3):
|
18.31 |
|
MA(250): |
7.54 |
%D(3): |
29.06 |
|
Average Volume(K) |
3-Month: |
21864
|
52-Week |
High:
|
11.38 |
|
10-Days: |
16286 |
Low: |
3.50 |
|
RSI |
RSI(14):
|
41.01 |
Change(%): |
-0.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.760 |
Return on Equity (ttm) |
-73.8 |
Shares Out. (M) |
47.94 |
|
EPS Est. Current Year |
-2.070 |
Return on Assets (ttm) |
-39.4 |
Shares Float (M) |
24.67 |
|
EPS Est. Next Year |
-2.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.53 |
|
EPS Est. Next Quarter |
-0.580 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
94.44 |
|
Forward EPS |
-2.450 |
Gross Profit (p.s.) |
-1.348 |
Shares Short (K) |
1760 |
|
Book Value (p.s.) |
3.050 |
EBITDA (p.s.) |
-1.666 |
P/E |
-4.33 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.50 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-74.94 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-49.87 |
P/CF |
-4.87 |
|
|
|
|
|
|
